AXIM BIOTECHNOLOGIES, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $8.2M | $2.1M | $1.8M |
| FY2019 | $8.5M | $1.7M | $511.6K |
| FY2020 | $9.7M | $11.3M | $457.2K |
| FY2021 | $7.7M | $5.3M | $453.0K |
| FY2022 | $9.0M | $4.2M | $47.3K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $8.2M | $2.1M | $1.8M |
| FY2019 | $8.5M | $1.7M | $511.6K |
| FY2020 | $9.7M | $11.3M | $457.2K |
| FY2021 | $7.7M | $5.3M | $453.0K |
| FY2022 | $9.0M | $4.2M | $47.3K |